Literature DB >> 15961147

Endogenous opioids are necessary for benzodiazepine palatability enhancement: naltrexone blocks diazepam-induced increase of sucrose-'liking'.

Derek K Richardson1, Sheila M Reynolds, Steven J Cooper, Kent C Berridge.   

Abstract

Opioid agonists and benzodiazepine agonists each increase food intake. Both also increase hedonic 'liking' reactions to sweet tastes in rats. Do opioids and benzodiazepines share overlapping mechanisms of hedonic impact? Or are benzodiazepine and opioid effects on hedonic impact mediated by independent mechanisms? The present study examined whether blockade of opioid receptors prevents benzodiazepine-induced enhancement of taste palatability, as assessed by the affective taste reactivity test. Rats were implanted with oral cannulae, and prior to an oral infusion of bittersweet quinine-sucrose solution, all received i.p. injections of either vehicle, or diazepam alone (5 mg/kg diazepam+0 mg/kg naltrexone), naltrexone alone (1 mg/kg naltrexone+0 mg diazepam), or both diazepam plus naltrexone (5 mg/kg diazepam+1mg/kg naltrexone). Videotaped hedonic ('liking') and aversive ('disliking') orofacial reactions elicited by sucrose/quinine taste were compared across drug conditions. Diazepam administration alone more than doubled hedonic 'liking' reactions to the bittersweet taste, while reducing 'disliking' in half, compared to vehicle levels. Naltrexone by itself had little effect on taste-elicited affective reactions, and only marginally increased aversive gapes. However, naltrexone completely blocked diazepam's enhancement of positive hedonic 'liking' reactions, and naltrexone similarly disrupted diazepam-reduction of aversive 'disliking' taste reactions. These results indicate that endogenous opioid neurotransmission may be crucial to benzodiazepine enhancement of hedonic 'liking' for natural taste reward.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15961147     DOI: 10.1016/j.pbb.2005.05.006

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  8 in total

Review 1.  Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions.

Authors:  Deanna M Barch; Erin C Dowd
Journal:  Schizophr Bull       Date:  2010-06-21       Impact factor: 9.306

2.  Neurophysiological differences in reward processing in anhedonics.

Authors:  Gonçalo Padrão; Aida Mallorquí; David Cucurell; Josep Marco-Pallares; Antoni Rodriguez-Fornells
Journal:  Cogn Affect Behav Neurosci       Date:  2013-03       Impact factor: 3.282

3.  In search of a theoretical structure for understanding motivation in schizophrenia.

Authors:  Alice Medalia; John Brekke
Journal:  Schizophr Bull       Date:  2010-06-30       Impact factor: 9.306

4.  Lateral septum inhibition reduces motivation for cocaine: Reversal by diazepam.

Authors:  Caroline B Pantazis; Gary Aston-Jones
Journal:  Addict Biol       Date:  2019-03-21       Impact factor: 4.280

5.  Multiple processes underlie benzodiazepine-mediated increases in the consumption of accepted and avoided stimuli.

Authors:  D W Pittman; M R McGinnis; L M Richardson; E J Miller; M L Alimohamed; J P Baird
Journal:  Chem Senses       Date:  2012-01-16       Impact factor: 3.160

6.  Reduced palatability in pain-induced conditioned taste aversions.

Authors:  Jian-You Lin; Joe Arthurs; Steve Reilly
Journal:  Physiol Behav       Date:  2013-06-13

Review 7.  Dissecting components of reward: 'liking', 'wanting', and learning.

Authors:  Kent C Berridge; Terry E Robinson; J Wayne Aldridge
Journal:  Curr Opin Pharmacol       Date:  2009-01-21       Impact factor: 5.547

8.  Pharmacological investigations of effort-based decision-making in humans: Naltrexone and nicotine.

Authors:  Cecilia Nunez; Jennifer K Hoots; Scott T Schepers; Michael Bower; Harriet de Wit; Margaret C Wardle
Journal:  PLoS One       Date:  2022-10-05       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.